Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
Peer-reviewedLicence not statedEuropean Journal of Medicinal Chemistry

Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors

Related

  1. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
    Eduard Badarau, Zhuo Wang, Dan Rathbone +6
    Chemistry and BiologyPeer-reviewedLicence not stated58 citedMolecular biology & gene regulationHAL
  2. Catamers: Multi-specific therapeutics that concatenate individual warheads on a DNA scaffold via Watson-Crick interactions
    J. Kamb, S. Xu, R. Burli +3
    bioRxivPreprintCC BYFull textMolecular biology & gene regulationbioRxiv
  3. Transglutaminase 3 is a Histone Monoaminylation Writer
    Y. Ritsema, H. Li, X. Ma +2
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  4. Immobilization of Microbial Transglutaminase for the Production of Homogeneous Immunotherapeutic Antibody-Drug Conjugates.
    M N Baranova, K A Sapozhnikova, E L Gulyak +6
    Acta naturaePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  5. Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights
    Tomojit Bhattacharjee, Ankush Kumar, Thakur Gurjeet Singh +1
    RSC Medicinal ChemistryPeer-reviewedPublisher termsFull textMolecular biology & gene regulationPMC
BibTeX
@article{badarau2026imidazoliumbased,
  title = {{Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors}},
  author = {Eduard Badarau and Alexandre Mongeot and Russell Collighan and Dan Rathbone and Martin Griffin},
  journal = {European Journal of Medicinal Chemistry},
  year = {2026},
  month = oct,
  doi = {10.1016/j.ejmech.2013.05.018},
  url = {https://hal.science/hal-05793303v1},
}
RIS
TY  - JOUR
TI  - Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
AU  - Eduard Badarau
AU  - Alexandre Mongeot
AU  - Russell Collighan
AU  - Dan Rathbone
AU  - Martin Griffin
PY  - 2026
DA  - 2026/10/12
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2013.05.018
UR  - https://hal.science/hal-05793303v1
SN  - 0223-5234
SN  - 1768-3254
ER  -